Working capital increased 24.0%
Working capital changed +24.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Working capital changed +24.0% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Inventory / revenue changed -468 basis points from the comparable as-filed period.
Stock-based compensation changed +78.1% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Operating cash-flow margin changed +445 basis points from the comparable as-filed period.
Operating cash flow / net income changed -39.5% from the comparable as-filed period.
Free-cash-flow margin changed +391 basis points from the comparable as-filed period.
Revenue changed +8.1% from the comparable as-filed period.
Gross profit changed +18.3% from the comparable as-filed period.
Current assets changed +7.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Working capital / assets changed +121 basis points from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed +53 basis points from the comparable as-filed period.
Cash & equivalents changed +3.3% from the comparable as-filed period.
Current ratio changed +2.1% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Total assets changed +0.5% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Current liabilities changed +5.3% from the comparable as-filed period.
Selling, general & administrative changed +7.5% from the comparable as-filed period.
SBC / revenue changed +16 basis points from the comparable as-filed period.
Inventory changed -1.3% from the comparable as-filed period.
Inventory / revenue changed -1354 basis points from the comparable as-filed period.
Revenue changed +15.9% from the comparable as-filed period.
Cash & equivalents changed +14.7% from the comparable as-filed period.
Stock-based compensation changed +14.3% from the comparable as-filed period. This reverses 3 consecutive comparable moves in the opposite direction.
Capex / revenue changed -30 basis points from the comparable as-filed period.
Capital expenditure changed -8.7% from the comparable as-filed period. The change ranks at the 0th percentile of 6 prior comparable changes.
Inventory changed -6.4% from the comparable as-filed period.
SBC / revenue changed -1 basis points from the comparable as-filed period.
Selling, general & administrative changed +0.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.